Single-dose HPV vaccination is currently being tested as a public health intervention with high impact. – – Medical Progress

Researchers released positive news Nov. 17 at Toronto’s 34 the International Papillomavirus Conference.
A randomized controlled trial of 2,275 women in Kenya revealed that a single dose of the human papillomavirus (HPV) vaccine was highly effective. The…

Click here to view the original article.